Global Report: Still Waiting - Pharmaceutical Executive


Global Report: Still Waiting
Industry and traders both want a decision on parallel trade in Europe—but not the same one.

Pharmaceutical Executive

"This [legal] reform may create the possibility to implement the dual price system," says Elizabeth Planell, an attorney with Baker & McKenzie's Barcelona office. "The laboratory would be able to check whether the medicines sold to wholesale distributors are supplied in the Spanish market or sold abroad, and to identify the distributor or pharmacy involved in parallel-trade activities. They could thus decide to apply different prices for medicines to such distributors, depending on whether or not the medicines are supplied to patients in Spain."

Sarah Houlton, PhD,is Pharmaceutical Executive's global correspondent. She can be reached at


blog comments powered by Disqus

Source: Pharmaceutical Executive,
Click here